Bancorp of New Jersey, Inc. Reports 23% Earnings Growth

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Bancorp of New Jersey, Inc. Reports 23% Earnings Growth Over First Quarter, 2014 and Record Asset Levels

FORT LEE, N.J., July 31, 2014 (GLOBE NEWSWIRE) -- Bancorp of New Jersey, Inc. (NYSE MKT:BKJ), the holding company of Bank of New Jersey, reported an increase of 23.8%, or $207 thousand, in net income from $871 thousand in the first quarter of 2014 to $1.1 million in the second quarter. Total assets, total loans, and total deposits each reached period-end record levels at June 30, 2014 as well. Although net interest income grew in both the three and six month periods ended June 30, 2014 compared to the corresponding periods of 2013, net income remained behind the corresponding periods of 2013 as a result of increased noninterest expense associated with branch expansion and, to a lesser extent, increased provisions for loan losses during 2014, primarily a result of strong loan growth. Net income for the six months ended June 30, 2014 reached $1.9 million compared to net income of $2.3 million for the six months ended June 30, 2013. This represents a decrease of approximately 13.8% in net income, or approximately $313 thousand. Earnings per diluted share were $0.36 for the six months ended June 30, 2014 compared to $0.42 per diluted share for the six months ended June 30, 2013. Net income for the second quarters of each of 2014 and 2013 was approximately $1.1 million. Earnings per diluted share were $0.20 for the quarter ended June 30, 2014, a decrease of $0.01, or 4.8%, from the diluted earnings per share of $0.21 for the quarter ended June 30, 2013. The net income generated during the quarter ended June 30, 2014 represents thirty consecutive quarters of profitability by the Company.

During the six months ended June 30, 2014, net interest income increased by $699 thousand, or 7.6%, reaching $9.9 million from $9.2 million for the six months ended June 30, 2013. During the second quarter of 2014, net interest income was $5.1 million and represented an increase of approximately $481 thousand, or 10.4%, from $4.6 million for the second quarter of 2013. The increased net interest income is primarily driven by interest income from loans as a result of increased loan production and higher average loan balances. During the first six months of 2014, non-interest expense, net, increased by $892 thousand, or 17.9%, reaching $5.9 million from $5.0 million for the first six months of 2013. During the second quarter of 2014, non-interest expense, net increased by $530 thousand, or 21.7%, and reached $3.0 million as compared to $2.4 million for the second quarter of 2013. The increase in non-interest expense, net, is primarily due to increased operating costs and salaries associated with expansion of the branch network as well as other costs associated with the Company's growth, including costs associated with enhanced technology and functionality for electronic banking. For the six months ended June 30, 2014, the provision for loan losses was $784 thousand, compared to provision for loan losses of $460 thousand, for the six months ended June 30, 2013. For the quarter ended June 30, 2014, the provision for loan losses was $344 thousand, compared to provision for loan losses of $320 thousand, for the three months ended June 30, 2013. These increases in the provision represent a direct relationship to the increased loan production during the first six months and the second quarter, respectively.

Bancorp of New Jersey's total assets reached a record level $642.6 million at June 30, 2014, compared to $610.8 million at December 31, 2013. Total loans reached $537.9 million at June 30, 2014, compared to $472.5 million at December 31, 2013, representing an increase of $65.5 million, or 13.9%. Total deposits increased to $577.2 million at June 30, 2014 from $553.3 million at December 31, 2013, an increase of $23.9 million, or 4.3%. Stockholder's equity increased to $58.2 million at June 30, 2014, from approximately $56.0 million at December 31, 2013.

Bank of New Jersey, headquartered at 1365 Palisade Avenue, Fort Lee, New Jersey, offers convenient hours and a high level of service for traditional consumer and commercial products and services. The Bank, currently, has 9 branch offices located in Fort Lee (3 locations), Hackensack, Haworth, Harrington Park, Englewood, Cliffside Park, and its most recent opening, in Woodcliff Lake, all in Bergen County, NJ. A tenth location in Englewood Cliffs, NJ, has received regulatory approvals from the FDIC and the NJDOBI. All locations are in Bergen County, NJ.

For more information about Bank of New Jersey and its products and services, please visit http://www.bonj.net or call 201-944-8600. 

If you would like to receive future Bancorp of New Jersey announcements electronically, please email us at shareholder@bonj.net

Forward-Looking Statements

This press release and other statements made from time to time by Bancorp of New Jersey's management contain express and implied statements relating to our future financial condition, results of operations, credit quality, corporate objectives, and other financial and business matters, which are considered forward-looking statements. These forward-looking statements are necessarily speculative and speak only as of the date made, and are subject to numerous assumptions, risks and uncertainties, all of which may change over time. Actual results could differ materially from those expected or implied by such forward-looking statements. Risks and uncertainties which could cause our actual results to differ materially and adversely from such forward-looking statements include economic conditions affecting the financial industry; changes in interest rates and shape of the yield curve; credit risk associated with our lending activities; risks relating to our market area, significant real estate collateral and the real estate market; operating, legal and regulatory risk; fiscal and monetary policy; economic, political and competitive forces affecting our business; and that management's analysis of these risks and factors could be incorrect, and/or that the strategies developed to address them could be unsuccessful. Any statements made that are not historical facts should be considered to be forward-looking statements. You should not place undue reliance on any forward-looking statements. We undertake no obligation to update forward-looking statements or to make any public announcement when we consider forward-looking statements to no longer be accurate, whether as a result of new information of future events, except as may be required by applicable law or regulation.

Bancorp of New Jersey, Inc.
Financial Highlights
(unaudited)
(dollars in thousands, except per share data)
         
         
  Three months ended Six months ended
  June 30, June 30,
INCOME STATEMENT 2014 2013 2014 2013
Net Interest Income $5,089 $4,608 $9,868 $9,169
Provision for loan losses 344 320 784 460
Noninterest Expense, net 2,973 2,443 5,869 4,977
Pretax Income 1,772 1,845 3,215 3,732
Tax Expense 694 728 1,266 1,470
Net Income $1,078 $1,117 $1,949 $2,262
         
Basic Earnings per Share $0.20 $0.21 $0.36 $0.43
Diluted Earnings per Share $0.20 $0.21 $0.36 $0.42
         
Weighted Average Shares – Basic 5,368 5,292 5,355 5,252
Weighted Average Shares – Diluted 5,436 5,367 5,424 5,335
         
         
SELECTED BALANCE SHEET DATA AT END OF PERIOD        
  6/30/2014 12/31/2013    
Total Loans $537,926 $472,465    
Allowance for Loan Losses 6,046 5,775    
Investment Securities 79,124 87,851    
Total Assets 642,610 610,791    
Total Deposits 577,209 553,320    
Stockholders' Equity 58,227 55,950    
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 314

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 187

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 129

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 287

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading

Top 5 Most Recently Viewed Articles

Elis Announces Share Buyback Operations Details and Impact

Updated Category News Views 257

Elis Announces Share Buyback Operations Recent Trading Disclosure by Elis In alignment with European regulations governing share buybacks, Elis has disclosed transactions for the purchase of its own shares. These operations occurred from September 15 to September 19, 2025, as part of an authorized buyback program approved by the General Shareholders' Meeting earlier in...

Continue Reading
One Stop Systems Set To Showcase Innovations at ROTH Event

Updated Category News Views 122

One Stop Systems Announces Participation in Major Conference One Stop Systems, Inc. (OSS), renowned for its cutting-edge solutions in rugged Enterprise Class computing, is gearing up to engage with investors at a prominent industry event. This year, OSS will be present at the 37th Annual ROTH Conference, scheduled for mid-March. The event will serve as a platform for the...

Continue Reading
Solid Biosciences to Engage at BioPharma Symposium Soon

Updated Category News Views 80

Solid Biosciences to Participate at BioPharma Symposium Solid Biosciences Inc. (NASDAQ: SLDB), a pioneering life sciences company, is excited to announce a significant upcoming event where they will showcase their advancements in the field of precision genetic medicine. The company's Chief Medical Officer, Dr. Gabriel Brooks, is scheduled to participate in a Genetic...

Continue Reading
JD Vance Confronted by Protesters While Out with Daughter

Updated Category News Views 378

Intense Encounter for Vice President JD Vance Recently, Vice President JD Vance found himself in a challenging situation when he was confronted by a group of pro-Ukraine protesters while spending time with his daughter. This encounter, which took place in Ohio, captured not only the essence of political tensions but also brought forth the complexities of personal moments...

Continue Reading
Exciting Addition to MyCardiologist as Dr. Koshy Joins Team

Updated Category News Views 325

New Addition to MyCardiologist Enhances Cardiovascular Care MyCardiologist, a leading name in advanced cardiovascular care, proudly announces the joining of Dr. Linda Koshy to their reputable medical team. Dr. Koshy is a skilled general and interventional cardiologist known for her exceptional ability to manage intricate coronary artery disease as well as endovascular...

Continue Reading